Deliver Your News to the World

CybeRelease: (OTC PK: MNCL) Retains Christopher Morgan for Infomercial Fulfillment


(CybeRelease, February 8, 2007) - Lake Harmony, PA - Martin Nutraceuticals Inc. (OTC PK: MNCL) is pleased to announce that it has selected and retained Christopher Morgan Fulfillment Services (CM) in Wisconsin to provide MNCL’s complete fulfillment needs. Mr. Harvey Panesar, President of Martin Nutraceuticals, stated that “it gives me a great sense of confidence that we have a highly respected, quality firm like Christopher Morgan handling the fulfillment of our infomercial demand. We certainly expect the infomercial for our future best-selling book, Medical Crisis: Secrets your Doctor won’t Share with You, will be an instant infomercial success. We anticipate demand for the book will be such that we will definitely need single a source fulfillment center such as a firm like Christopher Morgan. The Customer Response team at CM has proven to us that customers like Martin can depend on them to process customer orders promptly, accurately and efficiently on a cost-effective basis.”

About Christopher Morgan Fulfillment Services

Since 1997, Christopher Morgan has provided the e-commerce, financial, catalog and direct response television (DRTV) industry with fulfillment, assembly, distribution, customer care and integrated e-commerce expertise. Multiple distribution resources allows Christopher Morgan to ship a variety of products to any location worldwide via distribution partners UPS, FedEx, USPS and a variety of reliable common carriers. We offer live inventory status updates, order confirmation and tracking, return processing and other custom services.

Christopher Morgan works with strategic partners such as West Teleservices, Convergys, UPS, Fedex and USPS to service many clients with household names such as Travellers Insurance and Canella Response Television. CM is also a member of the Electronic Retailing Association and the Direct Marketing Association.

About Martin Nutraceuticals Inc.:

Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.

Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.

To read the complete release, go to

CybeRelease Gainers are Broadcom Corporation (Nasdaq: BRCM), Tellabs, Inc. (Nasdaq: TLAB), PMC - Sierra, Inc. (Nasdaq: PMCS), Xilinx, Inc. (Nasdaq: XLNX), Amkor Technology,

Inc. (Nasdaq: AMKR), Altera Corporation (Nasdaq: ALTR), Intersil Corporation (Nasdaq: ISIL) and Sycamore Networks, Inc. (Nasdaq: SCMR).

CybeRelease Decliners are JetBlue Airways Corporation (Nasdaq: JBLU), Art Technology Group, Inc. (Nasdaq: ARTG), Insmed, Inc. (Nasdaq: INSM), Digital River, Inc. (Nasdaq: DRIV), Pacific Sunwear of California, Inc. (Nasdaq: PSUN), TVIA, Inc. (Nasdaq: TVIA), Net.B@nk, Inc. (Nasdaq: NTBK) and Nuvelo, Inc. (Nasdaq: NUVO).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.